Skip CCR Main Navigation National Cancer Institute National Cancer Institute U.S. National Institutes of Health www.cancer.gov
CCR - For Our Staff| Home |

Our Science – Mock Website

Beverly Mock, Ph.D.

Selected Publications

1)  Simmons JK, Patel J, Michalowski A, Zhang S, Wei BR, Sullivan P, Gamache B, Felsenstein K, Kuehl WM, Simpson RM, Zingone A, Landgren O, Mock BA.
TORC1 and class I HDAC inhibitors synergize to suppress mature B cell neoplasms.
Mol Oncol. 8: 261-72, 2014.
[Journal]
2)  Zhang S, Pruitt M, Tran D, Du Bois W, Zhang K, Patel R, Hoover S, Simpson RM, Simmons J, Gary J, Snapper CM, Casellas R, Mock BA.
B Cell-Specific Deficiencies in mTOR Limit Humoral Immune Responses.
J. Immunol. 191: 1692-703, 2013.
[Journal]
3)  Zhang S, Readinger JA, DuBois W, Janka-Junttila M, Robinson R, Pruitt M, Bliskovsky V, Wu JZ, Sakakibara K, Patel J, Parent CA, Tessarollo L, Schwartzberg PL, Mock BA.
Constitutive reductions in mTOR alter cell size, immune cell development, and antibody production.
Blood. 117: 1228-38, 2011.
[Journal]
4)  Wu JJ, Liu J, Chen EB, Wang JJ, Cao L, Narayan N, Fergusson MM, Rovira II, Allen M, Springer DA, Lago CU, Zhang S, Dubois W, Ward T, Decabo R, Gavrilova O, Mock B, Finkel T.
Increased Mammalian Lifespan and a Segmental and Tissue-Specific Slowing of Aging after Genetic Reduction of mTOR Expression.
Cell Rep. 4: 913-20, 2013.
[Journal]
5)  Zhang K, Kagan D, Dubois W, Robinson R, Bliskovsky V, Vass WC, Zhang S, Mock BA.
Mndal, a new interferon-inducible family member, is highly polymorphic, suppresses cell growth and may modify plasmacytoma susceptibility.
Blood. 114: 2952-60, 2009.
[Journal]
6)  Smrž D, Bandara G, Zhang S, Mock BA, Beaven MA, Metcalfe DD, Gilfillan AM.
A novel KIT-deficient mouse mast cell model for the examination of human KIT-mediated activation responses.
J. Immunol. Methods. 390: 52-62, 2013.
[Journal]
7)  Simmons JK, Amlin-Van Schaick JC, Geiger TR, Reilly K, Hunter K, Mock BA.
Mouse genetics 2011: meeting report.
Mamm. Genome. 23: 225-31, 2012.
[Journal]
8)  Liu Z, Yang X, Li Z, McMahon C, Sizer C, Barenboim-Stapleton L, Bliskovsky V, Mock B, Ried T, London WB, Maris J, Khan J, Thiele CJ.
CASZ1, a candidate tumor-suppressor gene, suppresses neuroblastoma tumor growth through reprogramming gene expression.
Cell Death Differ. 18: 1174-83, 2011.
[Journal]
9)  Smrz D, Kim MS, Zhang S, Mock BA, Smrzová S, DuBois W, Simakova O, Maric I, Wilson TM, Metcalfe DD, Gilfillan AM.
mTORC1 and mTORC2 differentially regulate homeostasis of neoplastic and non-neoplastic human mast cells.
Blood. 118: 6803-13, 2011.
[Journal]
10)  Mock BA, Zhang S, Ramsay ES, Bliskovsky V, Zhang K, Shi W, DuBois W.
Strategies for dissecting complex traits associated with cancer: lessons from plasma cell tumors. In: AACR Education Book 2005.
Philadelphia: AACR; 2005. p. 273-276 [Book Chapter]
Click Here to View Expanded Bibliography.

This page was last updated on 5/8/2014.